Segment Information (Details) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013	Dec. 31, 2013
Segment Information
Depreciation and amortization	$ 610,515	$ 7,481	$ 1,088,619	$ 16,168
Segment profit	(610,000)	(7,000)	(1,089,000)	(17,000)
Operating expenses	3,897,000	8,090,000	4,790,000	10,139,000
Other (income) expenses	(52,352)	(10,573,737)	(43,697)	(10,316,480)
Impact of derivative securities		(9,217,000)		(10,390,000)
Net income (loss) from continuing ops.	(4,455,232)	2,476,647	(5,835,407)	126,778
Loss from discontinued ops.		(129,157)		(256,068)
Preferred dividends		47,250		171,625
Net loss attributable to common shareholders	(4,455,232)	2,300,240	(5,835,407)	(300,915)
Assets at end of period	54,529,269	197,000	54,529,269	197,000	18,344,052
Liabilities at end of period	9,232,010	8,767,000	9,232,010	8,767,000	11,878,894
Bio Pharma
Segment Information
Depreciation and amortization	610,000		1,089,000
Segment profit	(610,000)		(1,089,000)
Operating expenses	3,897,000		4,790,000
Other (income) expenses	(52,000)		(44,000)
Net income (loss) from continuing ops.	(4,455,000)		(5,835,000)
Net loss attributable to common shareholders	(4,455,000)		(5,835,000)
Assets at end of period	54,529,000		54,529,000
Liabilities at end of period	9,170,000		9,170,000
ProElite
Segment Information
Loss from discontinued ops.		(129,000)		(256,000)
Net loss attributable to common shareholders		(129,000)		(256,000)
Assets at end of period		26,000		26,000
Liabilities at end of period	62,000	1,517,000	62,000	1,517,000
Other
Segment Information
Depreciation and amortization		7,000		17,000
Segment profit		(7,000)		(17,000)
Operating expenses		8,090,000		10,139,000
Other (income) expenses		(1,356,000)		107,000
Impact of derivative securities		(9,217,000)		(10,390,000)
Net income (loss) from continuing ops.		2,476,000		(127,000)
Preferred dividends		47,000		172,000
Net loss attributable to common shareholders		2,429,000		(45,000)
Assets at end of period		172,000		172,000
Liabilities at end of period		$ 7,250,000		$ 7,250,000